Literature DB >> 22286959

Immunodetection of SV40 T/t-antigens in human osteosrcoma in a series of Tunisian patients.

S Ziadi1, H Boughamoura, M Ben Maitig, R Ben Gacem, S Mestiri, L Chaabani, M Trimeche.   

Abstract

Osteosarcoma is a primary bone malignancy that typically occurs during adolescence but also has a second incidence peak in the elderly. The etiology of osteosarcoma is not well understood. Recent investigations have identified SV40 DNA sequences in osteosarcomas, suggesting that SV40 may contribute to tumor development. However, these studies also demonstrated geographical differences in SV40-positive osteosarcomas. The purpose of this study was to determine the prevalence and clinicopathological characteristics of SV40 positive osteosarcoma in Tunisian patients. Fifty-six formalin-fixed paraffin-embedded specimens of osteosarcomas were retrospectively investigated. Samples investigated were clinical cases examined between 1990 and 2004 in the Laboratory of Pathology at the University Hospital Farhat-Hached of Sousse (Tunisia). The search for SV40 was performed by immunohistochemistry using the Pab108 antibody for the detection of the viral oncoproteins: large T antigen and small t antigen (T/t-ag). SV40 status was correlated with clinico-pathological data. T/t-ag immunostaning was detected in the tumor cells in 31/56 (55.4%) osteosarcoma cases. SV40 positivity was more frequent (83%) in patients older than 40 years (5/6 cases) than in patients under 40 years (52%, 26/50), but the difference does not reach statistical significance (p = 0.33). Moreover, the time between the onset of clinical symptoms and diagnosis was shorter for SV40 positive than SV40 negative cases (p = 0.08). However, the viral status did not differ significantly according to gender, tumor size, histological subtype, tumor location, or metastases. This study documents the presence SV40 T/t-antigens in a proportion of osteosarcomas in Tunisian patients. The expression of these viral oncoproteins supports the hypothesis that SV40 may have a role in the pathogenesis of this tumor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286959     DOI: 10.1007/s12253-012-9496-x

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  44 in total

1.  The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas.

Authors:  A De Luca; A Baldi; V Esposito; C M Howard; L Bagella; P Rizzo; M Caputi; H I Pass; G G Giordano; F Baldi; M Carbone; A Giordano
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

2.  B-cell origin of hamster lymphoid tumors induced by simian virus 40.

Authors:  J E Coe; I Green
Journal:  J Natl Cancer Inst       Date:  1975-01       Impact factor: 13.506

3.  SV40 T antigen alone drives karyotype instability that precedes neoplastic transformation of human diploid fibroblasts.

Authors:  F A Ray; D S Peabody; J L Cooper; L S Cram; P M Kraemer
Journal:  J Cell Biochem       Date:  1990-01       Impact factor: 4.429

4.  Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.

Authors:  D Malkin; S Chilton-MacNeill; L A Meister; E Sexsmith; L Diller; R L Garcea
Journal:  Oncogene       Date:  2001-07-27       Impact factor: 9.867

Review 5.  SV40 and human tumours: myth, association or causality?

Authors:  Adi F Gazdar; Janet S Butel; Michele Carbone
Journal:  Nat Rev Cancer       Date:  2002-12       Impact factor: 60.716

6.  Association of SV40 with human tumors.

Authors:  George Klein; Amy Powers; Carlo Croce
Journal:  Oncogene       Date:  2002-02-14       Impact factor: 9.867

Review 7.  BK and JC human polyomaviruses and simian virus 40: natural history of infection in humans, experimental oncogenicity, and association with human tumors.

Authors:  G Barbanti-Brodano; F Martini; M De Mattei; L Lazzarin; A Corallini; M Tognon
Journal:  Adv Virus Res       Date:  1998       Impact factor: 9.937

8.  Simian virus 40-like DNA sequences in human pleural mesothelioma.

Authors:  M Carbone; H I Pass; P Rizzo; M Marinetti; M Di Muzio; D J Mew; A S Levine; A Procopio
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

Review 9.  Simian virus 40 infection in humans and association with human diseases: results and hypotheses.

Authors:  Giuseppe Barbanti-Brodano; Silvia Sabbioni; Fernanda Martini; Massimo Negrini; Alfredo Corallini; Mauro Tognon
Journal:  Virology       Date:  2004-01-05       Impact factor: 3.616

Review 10.  Polyoma virus and simian virus 40 as cancer models: history and perspectives.

Authors:  Sarah J L Atkin; Beverly E Griffin; Stephen M Dilworth
Journal:  Semin Cancer Biol       Date:  2009-03-14       Impact factor: 15.707

View more
  3 in total

1.  No detection of simian virus 40 in malignant mesothelioma in Korea.

Authors:  Minseob Eom; Jamshid Abdul-Ghafar; Sun-Mi Park; Joung Ho Han; Soon Won Hong; Kun Young Kwon; Eun Suk Ko; Lucia Kim; Wan Seop Kim; Seung Yeon Ha; Kyo Young Lee; Chang Hun Lee; Hye Kyoung Yoon; Yoo Duk Choi; Myoung Ja Chung; Soon-Hee Jung
Journal:  Korean J Pathol       Date:  2013-04-24

2.  Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.

Authors:  Mauro Tognon; Alfredo Corallini; Marco Manfrini; Angelo Taronna; Janet S Butel; Silvia Pietrobon; Lorenzo Trevisiol; Ilaria Bononi; Emanuela Vaccher; Giuseppe Barbanti-Brodano; Fernanda Martini; Elisa Mazzoni
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

3.  Serum Antibodies Against Simian Virus 40 Large T Antigen, the Viral Oncoprotein, in Osteosarcoma Patients.

Authors:  Elisa Mazzoni; Ilaria Bononi; Maria S Benassi; Piero Picci; Elena Torreggiani; Marika Rossini; Andrea Simioli; Maria V Casali; Paola Rizzo; Mauro Tognon; Fernanda Martini
Journal:  Front Cell Dev Biol       Date:  2018-06-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.